JPS63223096A - Purified quaiac oil and its production - Google Patents
Purified quaiac oil and its productionInfo
- Publication number
- JPS63223096A JPS63223096A JP5616587A JP5616587A JPS63223096A JP S63223096 A JPS63223096 A JP S63223096A JP 5616587 A JP5616587 A JP 5616587A JP 5616587 A JP5616587 A JP 5616587A JP S63223096 A JPS63223096 A JP S63223096A
- Authority
- JP
- Japan
- Prior art keywords
- guaiac
- purified
- gel
- organic solvent
- porous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 241000147041 Guaiacum officinale Species 0.000 claims description 31
- 229940091561 guaiac Drugs 0.000 claims description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- 235000019197 fats Nutrition 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- 235000014121 butter Nutrition 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 5
- 102000003992 Peroxidases Human genes 0.000 claims description 5
- 229960000583 acetic acid Drugs 0.000 claims description 5
- 239000012362 glacial acetic acid Substances 0.000 claims description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 5
- 229920005654 Sephadex Polymers 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 230000008033 biological extinction Effects 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 6
- 235000019439 ethyl acetate Nutrition 0.000 claims 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 19
- 239000008103 glucose Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 210000001124 body fluid Anatomy 0.000 description 11
- 239000010839 body fluid Substances 0.000 description 11
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 229940039227 diagnostic agent Drugs 0.000 description 7
- 239000000032 diagnostic agent Substances 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000012535 impurity Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- OPAORDVBZRVVNQ-RNQWEJQRSA-N 4-[(z,2r)-4-(4-hydroxy-3-methoxyphenyl)-2,3-dimethylbut-3-enyl]-2-methoxyphenol Chemical compound C1=C(O)C(OC)=CC(C[C@@H](C)C(\C)=C/C=2C=C(OC)C(O)=CC=2)=C1 OPAORDVBZRVVNQ-RNQWEJQRSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- -1 Amyl alcohol ester Chemical class 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- OIXPKFRMEUTHOG-UHFFFAOYSA-N alpha-guaiaconic acid Chemical compound C1=C(O)C(OC)=CC(C2=C(C(C)=C(O2)C=2C=C(OC)C(O)=CC=2)C)=C1 OIXPKFRMEUTHOG-UHFFFAOYSA-N 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
に産業上の利用分野】
本発明は、体液中のブドウ糖ならびに潜血の検出を目的
とする診断薬の呈色指示薬として好適な精製グアヤク脂
ならびにその製造方法に関する。TECHNICAL FIELD The present invention relates to purified guaiac butter suitable as a color indicator for diagnostic agents aimed at detecting glucose and occult blood in body fluids, and a method for producing the same.
体液中のブドウ糖ならびに潜血の検出を目的とする診断
薬では呈色指示薬としてグアヤク脂を用いている。ブド
ウ糖或いは潜血を含有する体液と診断薬とが接触するこ
とにより、グアヤク脂が酸化を受けて青色に呈色するこ
とを利用して、体液中のブドウ糖或いは潜血を半定量的
に検出することが可能である。通常用いられるグアヤク
脂は天然グアヤク脂であり、熱帯性樹ユンウ木の心材よ
り採取されるため、α−グアヤコン酸、及びβ−グアヤ
コン酸、グアイアレチン酸、グアヤク酸。
レゼン、ゴム賀、精油など有効成分以外に複数の不純物
を含有し、かつ有効成分ならびに不純物の組成は一定で
ない。
呈色指示薬として天然グアヤク脂を用いた体液中のブド
ウ糖ならびに潜血の検出を目的とする診[!li薬では
、天然グアヤク脂に含有される不純物のために診断時の
呈色が不鮮明であること及び診断薬の保存安定性が不良
であることが問題となっている。Diagnostic agents aimed at detecting glucose and occult blood in body fluids use guaiac oil as a color indicator. Glucose or occult blood in body fluids can be detected semi-quantitatively by utilizing the fact that guaiac oil undergoes oxidation and turns blue when a diagnostic agent comes into contact with body fluids containing glucose or occult blood. It is possible. The commonly used guaiac fat is natural guaiac fat, which is extracted from the heartwood of the tropical tree guaya, and therefore contains α-guaiaconic acid, β-guaiaconic acid, guaiaretic acid, and guaiacic acid. It contains multiple impurities in addition to the active ingredients, such as rezene, gum buds, and essential oil, and the composition of the active ingredients and impurities is not constant. Diagnosis aimed at detecting glucose and occult blood in body fluids using natural guaiac oil as a color indicator [! Li drugs have problems in that the coloration during diagnosis is unclear due to impurities contained in natural guaiac oil, and the storage stability of the diagnostic agent is poor.
【発明が解決しようとする問題点1
本発明は、体液中のブドウ糖、ならびに潜血の検出を目
的とする診断薬の呈色指示薬として好適な、不純物を少
なくし、実質的に有効成分のみを含有する精製グアヤク
脂ならびにその製造方法を提供することを目的とする。
また、本発明においては、カラムを再利用できるものと
し、生産経費の低減を計ることを目的とする。
【問題点を解決するための手段]
本発明は、天然グアヤク脂を多孔質水酸基含有高分子物
質ゲルで有機溶剤を用いてカラムクロマ1−グラフィー
処理により分離して得られ、ペルオキシダーゼ及び過酸
化水素との反応後に測定して600n11における比吸
光係数E)二が200以上であり、かつRF値0.45
(トルエン/ジオキサン/氷酢酸=90/25/10
混合物)を有する精製グアヤク脂に係る。
本発明のグアヤク脂は、天然グアヤク脂をアセトンに溶
解し、トルエンを添加することによって生成した沈澱を
除去し、濾液を蒸発乾固して残渣を有機溶剤に溶解する
。この溶液を有機溶剤を用いて多孔質水酸基含有高分子
物質ゲルを充填したカラムに通してカラムクロマトグラ
フィーにより分離し、RFM 0.45 (トルエン
/ジオキサン/氷酢酸= 90/ 25/ 10 混
合物)を有するフラクションを補集して、捕集した溶液
から精製グアヤク脂を分離回収する。
本発明に用いる多孔質水酸基含有高分子物質ゲルとして
は、多孔質デキストランゲル(商品名5ephadex
Lll 、ファルマシア■製)、多孔質親水性ポリビ
ニール系ゲル(商品名トヨバール、東洋曹達工業@製)
等が挙げられる。また本発明に用いる有機溶剤としては
、低級アルコール、アセトン。
酢酸エステルなど高極性有機溶剤が好ましい。
本発明によって得られる精製グアヤク脂は、体液中のブ
ドウ糖、並びに潜血の検出を目的とする検査紙の呈色指
示薬として好適なものである。
体液検査体は公知の種々の方法によって製造されるが、
例えば呈色指示薬の他に糖酸化酵素、ペルオキシダーゼ
、湿潤剤、!fi1度調節反間安定剤。
pH1iii剤、結合剤及び吸水性粉末等を非水溶剤中
に溶解或いは分散してブドウ糖検出用インキ組成物をF
l製し、基材上に塗布することによって得られる。
体液中のブドウ糖は、グルコースオキシダーゼ等のブド
ウ糖酸化酵素の作用により、空気中の酸素と反応して最
終的にグルコン酸と過酸化水素に酸化される。生成した
過酸化水素は、ペルオキシダーゼの作用により発生期の
酸素を産生じ、この酸素は直ちにグアヤク脂と反応して
該指示薬を発色させる。この発色の程度により、体液中
のブドウ糖の有無並びにその量が半定量的に決定される
。
【実 施 例】
以下に本発明を実施例によって説明する。
精 グアヤク脂の 造
天然グアヤク脂100gをアセトン150−に溶解し、
攪拌下にトルエン1.5文を滴加し、沈澱物質(約20
9)を吸引濾過した。濾液を真空中で濃縮。
乾燥し、冑られた残渣(約70g)にエタノール100
−を加え、超音波処理で溶解した。この溶液を、予めエ
タノールで平衡化した疎水性デキストランゲル(商品名
5ephadex LH−20,ファルマシア■製)の
カラム(直径8(1’J1.高さ70σ)に添加し、エ
タノールで分離、溶出した。−回100dづつ分取し、
各フラクションについて薄層クロマトグラフィーで検査
後、所望するフラクションを集め、100dに濃縮した
。この溶液をn−ヘキサン2℃に加え再結晶させること
により、精製グアヤク脂約11gを得た。
精製 アヤク脂の確認
得られた精製グアヤク脂を珪酸ゲル調製板上にトルエン
/ジオキサン/氷酢酸(90/ 25/ 10 )混合
液で展開させ、ペルオキシダーゼ−[」202水溶液を
噴霧することにより、青色に呈色させたとコロ、RFI
O,45ヲWた。
10%H20□水溶液2−、エタノール4−9西洋わさ
びペルオキ・シダーゼ50myを蒸溜水で9.9dに調
製し、得られた精製グアヤク脂2qをエタノール20−
に溶解した溶液0.1dを加える。速やかに混合した溶
液を30秒後に14Jのキュベツト中60Or+1で透
過率を測定したところ、比吸光係数1%
[250を得た。
Cm
ブト 鞄検出用検査体の製法ならびに・能評価下記組成
のブドウ糖検出用インキ組成物をホモミキサーで微細分
散させた後、スクリーン印刷により、厚さ300μの白
色ポリスチレンシートに一辺が51mの四角形となるよ
うに印刷した。用いたスクリーン版は80メツシユ、レ
ジスト及びスクリーン紗の厚さの合計は130μであっ
た。
ブドウ糖検出用インキ組成物
ブドウ糖酸化酵素
(東洋紡製: Grade II )
3.6ffif1部ペルオキシダーゼ
(東洋紡製; Grade l[) 2
.4重量部精製グアヤク脂 4.8
重量部ソルビタンモノラウレート
(化工石鹸製ニスパン20) 7.2重量
部し一アスコルビルパルミテート 0.48 重量部
クエン酸 2.8重量部ク
エン酸ナトリウム 11.0ffiΦ部
メチルビニルエーテル/無ホマレ
イン酸共重合体(G、^、F社製:ガ
ントレッツ^N−169>のアミルアルコールエステル
化物 7.0重量部セルロース微粉末
(脂化成製:アビセルSF> 171重量
部n−アミルアルコール 228重量部ブ
チルセロソルブアセテート 33.5重量部得ら
れた印91物を60℃で40分間乾燥後、スティック状
に裁断してブドウ糖検出用検査体をt7た。
正常尿及び正常尿にβ−D−グルコースを50rRg/
dl、 100■/dl、 2501Mg/dl、 5
00I#g/dl、及び2000■/dlの濃度になる
ように溶解したものを検体として用い、スティックを浸
漬後直ちに取出して1分間静置し、検査試薬部の色調を
観察した。
検査試薬部の呈色は均−且つ鮮明であり、呈色した検査
体を室温で5分間静置しても色調の変化は認められなか
った。また、呈色濃度は検体中のブドウ糖濃度の増加に
伴って段階的に高くなり、上記の範囲内で検体中のブド
ウ糖濃度を明確に判別することが可能であった。
得られた検査体をガラス容器中に密封し、40℃で12
ケ月間保存した後、上記と同様にして試験を行ったとこ
ろ、検査試薬部の呈色は保存前と同様に均一、鮮明、且
つ安定であり、検体中のブドウIll濃度も保存前と同
様に明確に判別可能であった。
【比 較 例]
プ゛ 糖検1用検査体の製。ならびに性 評価実施例に
示した精製グアヤク脂のかわりに天然グアヤク脂を用い
る以外は、実施例と同様にしてブドウ糖検出用検査体を
臂だ。
正常尿及び正常尿にβ−D−グルコースを50/q/旧
、100η/旧、250■/旧、 500IRg/d
l、及び2000M / d lの濃度になるように溶
解したものを検体として用い、スティックを浸漬後直ち
に取出して1分間静置し、検査試薬部の色調を観察した
。
検査試薬部の呈色は実施例と比較して不鮮明かつ不均一
であった。甲信濃度は検体中のブドウ糖濃度の増加に伴
って段階的に高くなり、上記の範囲内で検体中のブドウ
糖をある程度判別可能であった。また、冑られた検査体
をガラス容器中に密封し、40℃で6ケ月保存した後、
上記と同様にして試験を行ったところ、保存前と比較し
て検査試薬部の呈色は不拘−且つ不鮮明となり、検体中
のブドウvJ濃度の判別も困難であった。
K発明の効果X
本発明によれば多孔質ゲルを充填したカラムを通すこと
によって粗グアヤク詣中の成分が分子量の大きい順に分
離溶出されるので実質的に有効な成分のみを含有する精
製グアヤク脂が得られる。
また、本発明においては分離能が極めて良好であり、カ
ラムの再利用が可能であるので経済的である。実施例に
記載のように呈色指示薬として本発明の製造方法で骨ら
れる精製グアヤク脂を用いた体液中のブドウ糖、ならび
に潜血の検出を目的とする診断薬では、実質的に不純物
を含有しないために、診断時の呈色が鮭明であり、かつ
診断薬の保存安定性が良好である。Problem to be Solved by the Invention 1 The present invention provides a material containing substantially only active ingredients with reduced impurities and suitable as a color indicator for diagnostic agents aimed at detecting glucose in body fluids and occult blood. The purpose of the present invention is to provide purified guaiac fat and a method for producing the same. Further, the present invention aims to reduce production costs by making the column reusable. [Means for Solving the Problems] The present invention is produced by separating natural guaiac butter using a porous hydroxyl group-containing polymeric gel using a column chromagraph treatment using an organic solvent, and peroxidase and hydrogen peroxide. The specific extinction coefficient E)2 at 600n11 measured after the reaction of is 200 or more, and the RF value is 0.45.
(Toluene/dioxane/glacial acetic acid = 90/25/10
(mixture) of purified guaiac fat. The guaiac butter of the present invention is prepared by dissolving natural guaiac fat in acetone, adding toluene to remove the generated precipitate, evaporating the filtrate to dryness, and dissolving the residue in an organic solvent. This solution was separated by column chromatography using an organic solvent through a column filled with a porous hydroxyl group-containing polymer gel, and RFM 0.45 (toluene/dioxane/glacial acetic acid = 90/25/10 mixture) was separated. The purified guaiac fat is separated and recovered from the collected solution. As the porous hydroxyl group-containing polymer material gel used in the present invention, porous dextran gel (trade name: 5ephadex
Lll, manufactured by Pharmacia ■), porous hydrophilic polyvinyl gel (trade name: Toyovar, manufactured by Toyo Soda Kogyo @)
etc. Further, examples of organic solvents used in the present invention include lower alcohols and acetone. Highly polar organic solvents such as acetate are preferred. The purified guaiac oil obtained by the present invention is suitable as a coloring indicator for test strips for the purpose of detecting glucose and occult blood in body fluids. Body fluid test specimens are manufactured by various known methods, but
For example, in addition to color indicators, sugar oxidase, peroxidase, wetting agents, etc. Fi1 degree adjustment stabilizer. An ink composition for glucose detection is prepared by dissolving or dispersing a pH 1iii agent, a binder, a water-absorbing powder, etc. in a non-aqueous solvent.
It can be obtained by making a liquid and coating it on a substrate. Glucose in body fluids reacts with oxygen in the air through the action of glucose oxidases such as glucose oxidase, and is finally oxidized to gluconic acid and hydrogen peroxide. The generated hydrogen peroxide produces nascent oxygen through the action of peroxidase, which immediately reacts with guaiac oil to cause the indicator to develop color. Based on the degree of color development, the presence or absence of glucose in the body fluid and its amount are determined semi-quantitatively. [Examples] The present invention will be explained below using examples. Dissolve 100g of purified natural guaiac butter in 150% acetone,
Add 1.5 grams of toluene dropwise with stirring to remove the precipitated material (approximately 20 g
9) was suction filtered. Concentrate the filtrate in vacuo. Add 100% ethanol to the dried and removed residue (about 70g)
- was added and dissolved by ultrasonication. This solution was added to a column (diameter 8 (1'J1. height 70σ) of hydrophobic dextran gel (trade name 5ephadex LH-20, manufactured by Pharmacia) that had been equilibrated with ethanol in advance, and separated and eluted with ethanol. .-Aliquot in 100d batches,
After testing each fraction by thin layer chromatography, the desired fractions were collected and concentrated to 100 d. About 11 g of purified guaiac fat was obtained by adding this solution to n-hexane at 2° C. and recrystallizing it. Purification Confirmation of guaiac fat The obtained purified guaiac fat was developed on a silicic acid gel preparation plate with a mixture of toluene/dioxane/glacial acetic acid (90/25/10), and by spraying an aqueous solution of peroxidase-202, a blue color was obtained. Tokoro, RFI
O, 45 w. 10% H20□ aqueous solution 2-9, ethanol 4-9 50 my of horseradish peroxysidase was prepared to 9.9 d with distilled water, and the obtained purified guaiac fat 2 q was mixed with ethanol 20-
Add 0.1 d of solution dissolved in . When the transmittance of the rapidly mixed solution was measured after 30 seconds at 60 Or+1 in a 14 J cuvette, a specific extinction coefficient of 1% [250] was obtained. Cm Buto Manufacturing method and performance evaluation of test specimen for bag detection After finely dispersing the ink composition for glucose detection with the following composition in a homomixer, a rectangular shape with a side of 51 m was printed on a white polystyrene sheet with a thickness of 300 μ by screen printing. I printed it like this. The screen plate used had 80 meshes, and the total thickness of the resist and screen gauze was 130 μm. Ink composition for glucose detection Glucose oxidase (manufactured by Toyobo: Grade II)
3.6ffif 1 part peroxidase (manufactured by Toyobo; Grade l[) 2
.. 4 parts by weight refined guaiac fat 4.8
Parts by weight Sorbitan monolaurate (Nispan 20 manufactured by Chemical Soap Co., Ltd.) 7.2 parts by weight Ascorbyl palmitate 0.48 parts by weight Citric acid 2.8 parts by weight Sodium citrate 11.0 parts by weight Methyl vinyl ether/non-fomaleic acid copolymer Amyl alcohol ester of combination (manufactured by G, ^, Company F: Gauntlets ^N-169) 7.0 parts by weight Cellulose fine powder (manufactured by Seikasei: Avicel SF> 171 parts by weight n-amyl alcohol 228 parts by weight Butyl cellosolve acetate 33 0.5 parts by weight of the obtained product marked 91 was dried at 60°C for 40 minutes and cut into sticks to obtain test specimens for glucose detection at t7.
dl, 100■/dl, 2501Mg/dl, 5
The sticks were dissolved to concentrations of 00I#g/dl and 2000#g/dl and used as specimens, and the sticks were taken out immediately after immersion, left to stand for 1 minute, and the color tone of the test reagent portion was observed. The coloration of the test reagent portion was uniform and clear, and no change in color tone was observed even when the colored test specimen was left standing at room temperature for 5 minutes. Further, the color density increased stepwise as the glucose concentration in the sample increased, and it was possible to clearly distinguish the glucose concentration in the sample within the above range. The obtained specimen was sealed in a glass container and heated at 40°C for 12
After storage for several months, a test was conducted in the same manner as above, and the color of the test reagent was uniform, clear, and stable as before storage, and the grape Ill concentration in the sample was also the same as before storage. It was clearly distinguishable. [Comparative example] Production of test specimen for sugar test 1. A test specimen for glucose detection was prepared in the same manner as in the example except that natural guaiac oil was used instead of the purified guaiac oil shown in the evaluation example. β-D-glucose in normal urine and normal urine 50/q/old, 100η/old, 250■/old, 500IRg/d
The stick was dissolved to a concentration of 2000 M/dl and 2000 M/dl as a specimen, and the stick was immediately taken out after immersion, left to stand for 1 minute, and the color tone of the test reagent portion was observed. The coloration of the test reagent portion was unclear and non-uniform compared to the example. The Koshin concentration increased stepwise as the glucose concentration in the sample increased, and it was possible to distinguish glucose in the sample to some extent within the above range. In addition, after sealing the test specimen in a glass container and storing it at 40°C for 6 months,
When a test was conducted in the same manner as above, the coloration of the test reagent part became unrestricted and unclear compared to before storage, and it was difficult to determine the grape vJ concentration in the sample. K Effects of the invention is obtained. Furthermore, the present invention has extremely good separation ability and is economical because the column can be reused. As described in the Examples, a diagnostic agent for the purpose of detecting glucose in body fluids and occult blood using purified guaiac fat produced by the production method of the present invention as a coloring indicator does not contain substantially impurities. In addition, the color appearance at the time of diagnosis is salmon bright, and the storage stability of the diagnostic agent is good.
Claims (1)
で有機溶剤を用いてカラムクロマトグラフィー処理によ
り分離して得られ、ペルオキシダーゼ及び過酸化水素と
の反応後に測定して600nmにおける比吸光係数E^
1^%_1_c_mが200以上であり、かつR_F値
0.45(トルエン/ジオキサン/氷酢酸=90/25
/10混合物)を有する精製グアヤク脂。 2、該多孔質水酸基含有高分子物質ゲルが多孔質デキス
トランゲルである特許請求の範囲第1項に記載の精製グ
アヤク脂。 3、該有機溶剤が低級アルコール、アセトン、酢酸エス
テル、或いはその混合物である特許請求の範囲第1項に
記載の精製グアヤク脂。 4、天然グアヤク脂をアセトンに溶解し、トルエンの添
加により生成する沈澱を除去し、濾液を蒸発乾固し、残
渣を有機溶剤に溶解し、この溶液を有機溶剤を用いて多
孔質水酸基含有高分子物質ゲルを充填したカラムに通し
て、カラムクロマトグラフィーにより分離し、R_F値
0.45(トルエン/ジオキサン/氷酢酸=90/25
/10混合物)を有するフラクションを捕集し、かつ捕
集した溶液から分離回収することを特徴とする精製グア
ヤク脂の製造方法。 5、該多孔質水酸基含有高分子物質ゲルが多孔質デキス
トランゲルである特許請求の範囲第4項に記載の精製グ
アヤク脂の製造方法。 6、該有機溶剤が低級アルコール、アセトン、酢酸エス
テル、或いはその混合物である特許請求の範囲第4項に
記載の精製グアヤク脂の製造方法。[Scope of Claims] 1. Obtained by separating natural guaiac butter using a porous hydroxyl group-containing polymer gel using column chromatography using an organic solvent, and measured at 600 nm after reaction with peroxidase and hydrogen peroxide. Specific extinction coefficient E^
1^%_1_c_m is 200 or more, and R_F value is 0.45 (toluene/dioxane/glacial acetic acid = 90/25
/10 mixture). 2. The purified guaiac fat according to claim 1, wherein the porous hydroxyl group-containing polymer substance gel is a porous dextran gel. 3. The purified guaiac butter according to claim 1, wherein the organic solvent is a lower alcohol, acetone, acetic ester, or a mixture thereof. 4. Dissolve natural guaiac butter in acetone, remove the precipitate formed by adding toluene, evaporate the filtrate to dryness, dissolve the residue in an organic solvent, and use the organic solvent to form a porous hydroxyl group-containing It was passed through a column filled with molecular substance gel and separated by column chromatography, with an R_F value of 0.45 (toluene/dioxane/glacial acetic acid = 90/25).
1. A method for producing purified guaiac fat, which comprises collecting a fraction having a mixture of 1. 5. The method for producing purified guaiac fat according to claim 4, wherein the porous hydroxyl group-containing polymer substance gel is a porous dextran gel. 6. The method for producing purified guaiac butter according to claim 4, wherein the organic solvent is a lower alcohol, acetone, acetic ester, or a mixture thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5616587A JPS63223096A (en) | 1987-03-11 | 1987-03-11 | Purified quaiac oil and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5616587A JPS63223096A (en) | 1987-03-11 | 1987-03-11 | Purified quaiac oil and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63223096A true JPS63223096A (en) | 1988-09-16 |
Family
ID=13019478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5616587A Pending JPS63223096A (en) | 1987-03-11 | 1987-03-11 | Purified quaiac oil and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63223096A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63223095A (en) * | 1987-03-11 | 1988-09-16 | 大日本印刷株式会社 | Purified quaiac oil and its production |
US5093082A (en) * | 1988-08-17 | 1992-03-03 | Dai Nippon Insatsu Kabushiki Kaisha | Purified guaiacum resin and method for making the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53127812A (en) * | 1977-04-09 | 1978-11-08 | Boehringer Mannheim Gmbh | Production of guayaconic acid a * diagnostic agent containing same and method for detecting lavent bleeding in excrement |
JPS63223095A (en) * | 1987-03-11 | 1988-09-16 | 大日本印刷株式会社 | Purified quaiac oil and its production |
-
1987
- 1987-03-11 JP JP5616587A patent/JPS63223096A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53127812A (en) * | 1977-04-09 | 1978-11-08 | Boehringer Mannheim Gmbh | Production of guayaconic acid a * diagnostic agent containing same and method for detecting lavent bleeding in excrement |
JPS63223095A (en) * | 1987-03-11 | 1988-09-16 | 大日本印刷株式会社 | Purified quaiac oil and its production |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63223095A (en) * | 1987-03-11 | 1988-09-16 | 大日本印刷株式会社 | Purified quaiac oil and its production |
US5093082A (en) * | 1988-08-17 | 1992-03-03 | Dai Nippon Insatsu Kabushiki Kaisha | Purified guaiacum resin and method for making the same |
US5621072A (en) * | 1988-08-17 | 1997-04-15 | Dai Nippon Insatsu Kabushiki Kaisha | Purified guaiacum resin and method for making same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3092465A (en) | Diagnostic test device for blood sugar | |
CA1115724A (en) | Diagnostic agent for the detection of occult blood in faeces | |
US4312834A (en) | Diagnostic agent for the detection of component materials in liquid and process for producing same | |
US3290117A (en) | Occult blood diagnostic composition with color enhancing agent | |
US3630957A (en) | Diagnostic agent | |
US4148611A (en) | Test composition, device and method for the detection of peroxidatively active substances | |
EP0029104B1 (en) | A composition, test device and method of making it, and method for the determination of an analyte in a liquid | |
Fairbridge et al. | The direct colorimetric estimation of reducing sugars and other reducing substances with tetrazolium salts | |
GB1601316A (en) | Polymeric composition for scientific analytic or diagnostic examinations | |
US3001915A (en) | Diagnostic composition | |
US4291121A (en) | Bilirubin-resistant determination of uric acid and cholesterol | |
JPS63223096A (en) | Purified quaiac oil and its production | |
US5093082A (en) | Purified guaiacum resin and method for making the same | |
Harrison | The product of the oxidation of glucose by glucose dehydrogenase | |
US4676950A (en) | Indicator and test device for detecting occult blood | |
JPS63223095A (en) | Purified quaiac oil and its production | |
JPS6259782B2 (en) | ||
JPS6036757B2 (en) | Test device for detecting lactase in meconium samples | |
DE2114638A1 (en) | Method for the determination of peroxides | |
Graham | XXXV.—On liquid diffusion applied to analysis | |
JP2610460B2 (en) | Occult blood detection composition and test body using the same | |
DE3016618C2 (en) | Test agent using polymer-bound chromogens that can be oxidized with respect to the peroxidase-hydrogen peroxide system | |
JPS61268199A (en) | Test paper for determination of bile acid and production thereof | |
JP2948654B2 (en) | Test strip for detecting peroxidase active substance | |
RU2247372C2 (en) | Method for assay of blood trace by oxidation reaction of 3,3',5,5'-tetramethylbenzidine |